MedPath

Finlay Vaccine Institute

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 1:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 1
1 (50.0%)
No trials found

News

Cuba Begins Clinical Trial of New 11-Valent Pneumococcal Vaccine in Adults

Cuba has initiated a Phase II-III clinical trial to assess the safety, immunogenicity, and efficacy of a new 11-valent pneumococcal vaccine, Quimio-Vio, in adults aged 50-74.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.